Limestone Investment Advisors LP

Position in DMII — Drugs Made In America Acquisition II Corp.

CIK 2075597 NEW YORK, NY

Position in DMII

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$118,643

New position

Shares Held

11,900

first reported quarter

Ownership

0.019%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Financial Services · as of Mar 31, 2026

Limestone Investment Advisors LP holds $5,920,629 across 4 Shell Companies names. DMII ranks #4 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HYAC	Haymaker Acquisition Corp. 4	392,164	$4,525,572
2	RFAM	RF Acquisition Corp III	70,731	$692,456
3	XFLH	XFLH Capital Corp	59,165	$583,958
4	DMII	Drugs Made In America Acquisition II Corp. This page	11,900	$118,643

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$118,643	11,900	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.